Home/Filings/4/0001179110-06-015238
4//SEC Filing

WATSON PHARMACEUTICALS INC 4

Accession 0001179110-06-015238

CIK 0000884629operating

Filed

Jul 16, 8:00 PM ET

Accepted

Jul 17, 4:59 PM ET

Size

7.6 KB

Accession

0001179110-06-015238

Insider Transaction Report

Form 4
Period: 2006-07-17
HSIA DAVID C
Sr. VP, Scientific Affairs
Transactions
  • Gift

    Common Stock, par value $0.0033

    2006-07-17879732,085 total(indirect: By Trust)
Holdings
  • Common Stock, par value $0.0033

    (indirect: By Partnership)
    1,004,218
  • Common Stock, par value $0.0033

    (indirect: By Trust)
    40,000
  • Common Stock, par value $0.0033

    61,333
Footnotes (3)
  • [F1]By Family Trust refers to the Hsia Family Trust, of which Dr. Hsia is a beneficial owner.
  • [F2]By Partnership refers to the Hsia Interests, Ltd., of which Dr. Hsia is a general partner.
  • [F3]This includes 1,333 shares of restricted stock issued pursuant to the Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.

Issuer

WATSON PHARMACEUTICALS INC

CIK 0000884629

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0000884629

Filing Metadata

Form type
4
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:59 PM ET
Size
7.6 KB